DSS is a multi-national portfolio company that operates 10 business lines across high-growth sectors like direct selling, fintech, and healthcare. It acquires and operates entities, with a goal of strategically spinning them out through IPOs to deliver shareholder value. DSS has seen significant growth in recent years, with revenues increasing 30% and total assets growing over $127 million from 2020 to Q3 2021. It aims to continue expanding its market share and assets, achieve positive EBITDA, and establish objectives and metrics to increase shareholder value through future IPOs.
2. Who Is DSS?
DSS is a multi-national portfolio company that now operates 10 business lines with
approximately 40 subsidiaries.
Our Ethos
DSS empowers companies to create value by enabling opportunistic transformation spurred
by innovation, industry needs, and asset acquisitions.
Our Approach
DSS acquires entities and operates within multiple high-growth sectors. Our business model is
based on a distribution sharing system in which shareholders will receive shares in its
subsidiaries as DSS strategically spins them out into IPOs.
2
3. Why Invest in
These Areas?
The opportunities within our business
lines and high-growth markets have
unlimited potential. Entities within
these sectors are contemporary,
scalable, offer recurring revenue
opportunities.
Market Potential
Direct selling is a global business of $167 billion and is projected
to have its fifth year of double-digit growth. The new Gig Economy
projected to surpass $1.3 trillion by 2028.
Consumer Packaging and folding carton market are expected to
reach $166 billion by 2026 with a CAGR of 5%.
Biohealth generates $752 billion in the US alone.
Fintech firms have raised $22.8 billion in the first half of 2021
through investments. Blockchain is a global business of $3.6
billion.
Securities is a high-growth sector of $70 trillion.
REITs have doubled from 23% to 44% in the last two decades.
Digital Transformation (DX) is projected to reach $1.8 trillion in
2022, and by 2025 is forecasted to reach $2.8 trillion.
3
4. 4
Leadership
Our entire leadership team
consists of global directors with
immense experience and talent.
Our team of leadersβ experience
and expertise spans the breadth
of our business lines and
investment sectors.
Frank D. Heuszel
Chief Executive Officer
Areas of expertise: Asset Management,
Financial Engineering and Legal
Jason T. Grady
Chief Operating Officer,
President of Premier Packaging Corporation
Areas of expertise: Operations,
Sales Management, Investor Relations
Todd D. Macko
Chief Financial Officer
Areas of expertise: Risk Mitigation and Competitive Analysis
Heng Fai Ambrose Chan
Executive Chairman of the Board
Areas of expertise: Financial Restructuring,
Corporate Transformation
4
5. Our Business Lines
β Direct Selling
β Banking and Lending
β Securities
β Consumer Packaging
β BioHealth
β Healthy Living
β Cryptocurrency Exchanges
β Blockchain
β Software Applications Development
β Energy and Solar
10
Business
Lines ~40
Subsidiaries
Multiple
High-Growth
Sectors
5
6. DSS, INC.
DSS
International,
Inc.
(Nevada)
DSS
Blockchain
Security, Inc.
(Nevada)
DSS
Secure Living,
Inc.
(Nevada)
DSS
Securities,
Inc.
(Nevada)
Alset Energy
Inc.
(Texas)
DSS
Technology
Management,
Inc.
(Delaware)
DSS
BioHealth
Security, Inc.
(Nevada)
American
Pacific
Bancorp-APB
(Texas)
Decentralized
Sharing
Systems, Inc.
(Nevada)
Premier
Packaging
Corporation
(NY)
DSS Digital
Transforma
-tion, Inc.
(HK)
Guangzhou
HotApp
Technology
LTD.
DSS Cyber
Security
Pte,
LTD.
USX
Holdings
Company,
Inc. (70%)
USX
Securities,
Inc.
USX
Digital,
Inc.
DSS Asset
Manage-
ment, Inc.
(TX)
American
Medical
REIT Inc.
(AMRE)
(Maryland)
(93%)
Alset Title
Company,
Inc.
(70%)
(Texas)
DSS
Financial
Manage-
ment,
Inc. (Texas)
Alset Solar,
Inc.
(Nevada)
AMRE
PROPERTIES
WESTPARK
CAPITAL
7.5%
AMRE Asset
Management
Inc. (AAMI)
(53%)
Nevada
Global
Solar
REIT, Inc.
(Maryland)
TBD (Mngt
Company)
USMedical
REIT
(Maryland)
PRESIDIO
EXPRESS
MOBILE INC. THERAPIX
Impact
BioMedical
(Nevada)
Alset
OpenBiz,
Inc.
(Texas)
Gigenomics
Solutions,
Inc.
(Texas)
RBC
Life World,
Inc.
(Nevada)
HWH
World,
Inc.
(Texas)
SHRG
β 58%
RBC Life
Internatio-
nal, Inc.
(Nevada)
HWH
Malaysia
TBD
TR PK
Distribution
SED
Global
Biomedical,
Inc.
(Nevada)
Sweet
Sense, Inc.
(Nevada)
50% BioLife
Sugar 50%
Impact
DSS
Biomedical
Internatio-
nal, Inc.
(Nevada)
Impact
Biolife
Science,
Inc.
(Nevada)
20% GRDG
Impact
Oncology,
Pte.
VIVACITAS
ONCOLOGY
15.34%
DSS
PureAir,
Inc.
(Texas)
Global
Sugar
Solutions,
Inc.
(Nevada)
DSS Biolife
Internatio-
nal, Inc.
(Nevada)
Global
Biolife,
Inc.
(Nevada)
20% GRDG
10% Holista
BioMed
Technology
Probiotics
Distribution
Happy
Sugar,
Inc.
(Nevada)
Nano 9
Labs LLC
Biolife
Sugar,
Inc.
(Nevada)
LVAM
60%
HK Corp
Cayman
Islands LVI
ETF Fund
DSS
Wealth
Manage-
ment, Inc.
DSS
America-
First
Sentinel
Brokers
LLC
90%
Sentinel
Brokerage,
Inc. 24.9%
BMI CI
24.9%
Wholly-Owned Subsidiary
Subsidiary (> 50% & <100%)
Investment (< 20%)
Affiliate (< 50%)
7. How Do We Create
Shareholder Value?
Key Areas for Growth
1. Buying Assets: Securing vehicles and
infrastructure to be able to generate
revenue.
2. Generation of Revenue: Identifying
the business needs and empowering
those businesses to be successful.
3. Positive EBITDA: Achieving positive
EBITDA by creating size and efficiency
within those businesses.
7
11. The Future of DSS
Our Projected Goals and Metrics
β Increase Shareholder Value
β Create Value through IPOs
β Increase Market Share
β Establish OKR Methodology:
Objectives and Key Results
β Invest in Quality Management and
Talent Acquisition
β Positive Adjusted EBITDA
11
12. Delivering Shareholder Value
Contact Us
Investor Contact:
Dave Gentry, CEO
RedChip Companies Inc.
(407) 491-4498
Dave@redchip.com
WWW.DSSWORLD.COM
12